Search results for "IPR"

showing 10 items of 1515 documents

SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF 3-AMINO-N-PHENYL-1H-INDAZOLE-1-CARBOXAMIDES

2010

Recently our research group has reported the synthesis of some 3-amino-N-phenyl-1H-indazole-1-carboxamides able to inhibit at low micromolar concentrations the cell growth of many neoplastic cell lines. The above compounds are unsubstituted in the indazole nucleus and this gives the hope to obtain more active compounds if appropriate substituents are beared by the above nucleus. So, several new N-phenyl-1H-indazole-1-carboxamides 1c-h and 4l,m were prepared by reacting phenyl isocyanates 3a,b with 3-amino-1H-indazoles 2c,e,g, or 1H-indazole 2l respectively. Chemical trasformations of compounds 1a,b and 1g,h gave 3-acetamido-N-phenyl-1H-indazole-1-carboxamides 5a,b, and 3,5-diamino-N-phenyl-…

3-amino-N-phenyl-1H-indazole-1-carboxamides antiproliferative activitySettore CHIM/08 - Chimica Farmaceutica
researchProduct

Synthesis, antiproliferative activity and possible mechanism of action of novel 2-acetamidobenzamides bearing the 2-phenoxy functionality.

2015

Several new 2-(2-phenoxyacetamido)benzamides 17a-v, 21 and 22 were synthesized by stirring in pyridine the acid chlorides 16a-e and the appropriate5-R-4-R1-2-aminobenzamide 15a-e and initially evaluated in vitro for antiproliferative activity against the K562 (human chronic myelogenous leukemia) cell line. Some of synthesized compounds were evaluated for their in vitro antiproliferative activity against the full NCI tumor cell line panel derived from nine clinically isolated cancer types (leukemia, non-small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast). The most active compounds caused an arrest of K562 cells in the G0-G1 phase of cell cycle and induction of apoptos…

3003Clinical BiochemistryCellPharmaceutical ScienceAntineoplastic AgentsApoptosisAntiproliferative activityPharmacologyG0/G1 arrestBiochemistryArticle2-(2-Phenoxyacetamido)benzamideAntineoplastic AgentStructure-Activity RelationshipBenzamideSettore BIO/10 - BiochimicaCell Line TumorDrug DiscoveryG1 Phase Cell Cycle CheckpointK562 CellmedicineHumansMolecular BiologyCell ProliferationCell growthChemistryDrug Discovery3003 Pharmaceutical ScienceOrganic ChemistryApoptosiCell cyclemedicine.diseaseCaspaseSettore CHIM/08 - Chimica FarmaceuticaG1 Phase Cell Cycle CheckpointsLeukemiamedicine.anatomical_structureMicroscopy FluorescenceCell cultureApoptosisCaspasesBenzamidesMolecular MedicineDrug Screening Assays AntitumorK562 CellsPro-caspase 3HumanK562 cellsChronic myelogenous leukemiaBioorganicmedicinal chemistry
researchProduct

"Table 1" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Raw primary antiproton-to-proton ratio as a function of the momentum p_primary.

5020.0P PB --> XNuclear TheoryPhysics::Accelerator PhysicsRAW_PBAR_PHigh Energy Physics::ExperimentPhysics::Atomic PhysicsNuclear ExperimentRaw antiproton-to-proton ratio
researchProduct

"Table 7" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Raw primary antiproton-to-proton ratio from Geant4-based MC simulations as a function of the momentum p_primary with sigma_inel(pbar)0.75.

5020.0P PB --> XPhysics::Accelerator PhysicsRAW_PBAR_PHigh Energy Physics::ExperimentNuclear ExperimentRaw antiproton-to-proton ratio
researchProduct

"Table 5" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Raw primary antiproton-to-proton ratio from Geant4-based MC simulations as a function of the momentum p_primary with default sigma_inel(pbar).

5020.0P PB --> XPhysics::Accelerator PhysicsRAW_PBAR_PHigh Energy Physics::ExperimentNuclear ExperimentRaw antiproton-to-proton ratio
researchProduct

"Table 6" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Raw primary antiproton-to-proton ratio from Geant4-based MC simulations as a function of the momentum p_primary with sigma_inel(pbar)x1.25.

5020.0P PB --> XPhysics::Accelerator PhysicsRAW_PBAR_PHigh Energy Physics::ExperimentNuclear ExperimentRaw antiproton-to-proton ratioPhysics::Atmospheric and Oceanic Physics
researchProduct

"Table 12" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Inelastic interaction cross section of antiprotons on an averaged material element of the ALICE detector (2 sigma constraints).

5020.0Physics::Instrumentation and DetectorsP PB --> XHigh Energy Physics::ExperimentAntiproton inelastic c.s.Nuclear ExperimentSIG_INEL
researchProduct

"Table 10" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Inelastic interaction cross section of antiprotons on an averaged material element of the ALICE detector (2 sigma constraints).

5020.0Physics::Instrumentation and DetectorsP PB --> XHigh Energy Physics::ExperimentAntiproton inelastic c.s.Nuclear ExperimentSIG_INEL
researchProduct

"Table 11" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Inelastic interaction cross section of antiprotons on an averaged material element of the ALICE detector (1 sigma constraints).

5020.0Physics::Instrumentation and DetectorsP PB --> XHigh Energy Physics::ExperimentAntiproton inelastic c.s.Nuclear ExperimentSIG_INEL
researchProduct

"Table 9" of "Measurement of the low-energy antideuteron inelastic cross section"

2020

Inelastic interaction cross section of antiprotons on an averaged material element of the ALICE detector (1 sigma constraints).

5020.0Physics::Instrumentation and DetectorsP PB --> XHigh Energy Physics::ExperimentAntiproton inelastic c.s.Nuclear ExperimentSIG_INEL
researchProduct